France Warns Of Risk Of Severe Skin Reactions With Lung Cancer Drug Krazati
Executive Summary
The French regulator says “additional investigations” are being conducted into a fatal case of Lyell syndrome and other reports of serious cutaneous side-effects, with a view to taking “appropriate measures.”